Keywords: astrazeneca, naropin, gets, new, use, eu, anglo-swedish

AstraZeneca's Naropin gets new use in EU

Article | 22 December 2003

Print This

Anglo-Swedish drug major AstraZeneca's long-acting anesthetic Naropin(ropivacaine) has been approved for a new use in the European Union. The ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in